Guillermo Flores

Guillermo Flores

Auto-generated profile, based on publicly available information

Guillermo Flores

Servicio de Medicina Interna, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México, México

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2002 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
GFGuillermo Flores
Guillermo Flores
HNHaiko Nellen
Haiko Nellen
FMFrancisco Magaña
Francisco Magaña
JCJuan Calleja
Juan Calleja
Bilateral emphysematous pyelonephritis is a life threatening condition usually occurring in diabetics. Management of this condition has traditionally been aggressive and surgery is considered mandatory. However, this is itself a hazardous intervention in a septic, unstable patient with circulatory or liver failure. When bilateral disease is present, the need for long-term dialysis is obviously unavoidable. We herein report one of the few cases of bilateral emphysematous pyelonephritis successfully managed by non-surgical treatment.

1 June 1996 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
DBDaniel Batlle
Daniel Batlle
GFGuillermo Flores
Guillermo Flores

1 November 2002 in Archives of Medical Research
Verified
Journal Article
Closed access
CPCynthia S Palmer
Cynthia S Palmer
EBElizabeth Brunner
Elizabeth Brunner
LRLuis Guillermo Ruı́z-Flores
Luis Guillermo Ruı́z-Flores
FPFrancisco Paez-Agraz
Francisco Paez-Agraz
DRDennis A Revicki
Dennis A Revicki

16 January 2004 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
GFGuillermo Flores
Guillermo Flores
SPSantiago Perez-Patrigeon
Santiago Perez-Patrigeon
CCCarolina Cobos-Ayala
Carolina Cobos-Ayala
JVJesus Vergara
Jesus Vergara
Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone is an uncommon complication of treatment with the new class of antidepressant agents, the selective serotonin reuptake inhibitors. The risk of hyponatremia seems to be highest during the first weeks of treatment particularly, in elderly females and in patients with a lower body weight. A 61-year-old diabetic male was admitted to the hospital because of malaise, progressive confusion, and a tonic/clonic seizure two weeks after starting citalopram, 20 mg/day. On physical examination the patient was euvolemic and had no evidence of malignancy, cardiac, renal, hepatic, adrenal or thyroid disease. Laboratory tests results revealed hyponatremia, serum hypoosmolality, urine hyperosmolarity, and an elevated urine sodium concentration, leading to the diagnosis of inappropriate secretion of antidiuretic hormone. Citalopram was discontinued and fluid restriction was instituted. The patient was discharged after serum sodium increased from 124 mmol/L to 134 mmol/L. Two weeks after discharge the patient denied any new seizures, confusion or malaise. At that time his serum sodium was 135 mmol/L. Because the use of serotonin reuptake inhibitors is becoming more popular among elderly depressed patients the present paper and other reported cases emphasize the need of greater awareness of the development of this serious complication and suggest that sodium serum levels should be monitored closely in elderly patients during treatment with citalopram.

1 January 2014 in World Journal of Gastroenterology
Verified
Journal Article
Open access
CLCarlos Alberto García López
Carlos Alberto García López
FLFernando Laredo-Sánchez
Fernando Laredo-Sánchez
JMJosé Malagón-Rangel
José Malagón-Rangel
MFMiguel G Flores-Padilla
Miguel G Flores-Padilla
HNHaiko Nellen-Hummel
Haiko Nellen-Hummel
Intestinal pseudo-obstruction secondary to systemic lupus erythematosus (SLE) is a rare syndrome described in recent decades. There are slightly over 30 published cases in the English language literature, primarily associated with renal and hematological disease activity. Its presentation and evolution are a diagnostic challenge for the clinician. We present four cases of intestinal pseudo-obstruction due to lupus in young Mexican females. One patient had a previous diagnosis of SLE and all presented with a urinary tract infection of varying degrees of severity during their evolution. We consider that recognition of the disease is of vital importance because it allows for establishing appropriate management, leading to a better prognosis and avoiding unnecessary surgery and complications.

1 January 1996 in Hypertension
Verified
Journal Article
Closed access
PDF file
MYMinghao Ye
Minghao Ye
GFGuillermo Flores
Guillermo Flores
DBDaniel Batlle
Daniel Batlle
The aim of the present study was to define the effects of angiotensin II (Ang II) and Ang-(1-7) on free cytosolic Na + (Na + i ), intracellular pH (pH i ), and the Na + -H + antiporter in cultured vascular smooth muscle cells from rat aorta. Cells were loaded with either BCECF-AM or SBFI-AM for measurement of pH i and Na + i , respectively. Ang II (10 −6 mol/L) caused a rapid rise in Na + i followed by a progressive increase that peaked at about 10 minutes (from 11±1.5 to 16±1.5 mmol/L, P <.001), whereas Ang-(1-7) (10 −6 mol/L) did not affect Na + i significantly (from 11.5±1.1 to 11.8±0.07 mmol/L). The effect of Ang II on Na + i was concentration dependent (ΔNa + i , 5.1±0.9, 3.8±0.6, 1.6±0.6, and 0.14±0.18 mmol/L with decreasing concentrations of 10 −6 , 10 −7 , 10 −8 , and 10 −9 mol/L, respectively). Ang II caused a brief acidification followed by an increase in pH i (from 7.34±0.03 to 7.43±0.03 after 10 minutes, P <.005), and Ang-(1-7) had no significant effect on pH i (from 7.23±0.03 to 7.23±0.03). To investigate whether pH i and Na + i changes induced by Ang II were due to cell Na + entry via stimulation of the Na + -H + antiporter, we pretreated cells with EIPA (25 μmol/L) or ouabain (2.0 mmol/L). Ang II in the presence of ouabain caused a greater increase than that seen with ouabain alone (ΔNa + i , 13±1.5 versus 6.3±1.2 mmol/L, P <.0025). EIPA by itself decreased Na + i and pH i . After EIPA, Ang II failed to increase both Na + i and pH i , demonstrating that the Na + -H + antiporter is responsible for the rises in Na + i and pH i during stimulation with Ang II. To further characterize the mechanism of Ang II action, we exposed cells to an Ang II type 1 receptor antagonist (L-158,809, 10 −6 mol/L) or two different type 2 receptor antagonists (PD 123177 and CGP 421112A, 10 −6 mol/L). L-158,809 completely blocked the rise in pH i caused by Ang II, whereas PD 123177 and CGP 421112A did not. We conclude that Ang II increases both Na + i and pH i , and both effects are mediated by stimulation of the Na + -H + antiporter. Ang-(1-7), by contrast, has no significant effect on Na + i , pH i , or the Na + -H + antiporter. Stimulation of this antiporter by Ang II is exerted through the type 1 receptor.